Group coronavirus testing helps make most of limited kits

With one kit, researchers effectively tested 64 people for COVID-19.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

In March, with the number of coronavirus cases across the world creeping higher and higher, the World Health Organization issued a simple directive to anyone who would listen: “test, test, test.”

But with too many people and too few test kits, researchers across the world are having to improvise, using group coronavirus testing as a way to dramatically increase their testing capabilities.

“This approach should reduce the chance of infection and flatten the infection curve.”


Roy Kishony

Group testing, also known as pool testing, is a technique that’s been around since World War II, when the U.S. Army first employed it to suss out syphilitic soldiers.

Rather than pay for each soldier to undergo a costly test, officials would combine blood samples from a group of soldiers and then test that joint sample.

If the test came back negative, all the men could be assumed free of the disease. If it came back positive, the Army could test the soldiers in that group individually to find the one (or more) with syphilis

Now, researchers in the United States, Israel, and other nations are employing the technique to the coronavirus outbreak  — and they’re finding the method to be incredibly effective.

On March 24, Peter Iwen, director of Nebraska’s Public Health Lab, began using group coronavirus testing as a way to save valuable time and supplies.

He split 60 samples into 12 groups of five before testing, and found he was able to effectively identify all of the positive samples in the group using 24 kits instead of the usual 60.

“He saved more than 50% of the reagents by doing it that way” Nebraska’s Chief Medical Officer Gary Anthone told KETV. “It’s an ingenious idea.”

During a group coronavirus testing trial in Israel, meanwhile, researchers tested up to 64 samples at once — and if even one sample in the group was positive, the test was able to detect it.

Studies of group coronavirus testing in Germany and Austria found the technique to be effective as well.

“The results give cause for optimism that when globally established, the procedure will quickly enable better information about the number of people actually infected,” Sandra Ciesek, a lead researcher of the German study, said in a news release.

Based on these results, implementing group coronavirus testing on a wide scale could allow nations to dramatically increase the number of people they test.

According to the German team, their nation could immediately go from a daily testing rate of 40,000 people to upwards of 400,000 people — all without any drop in the quality of the diagnosis.

“This is not a scientific breakthrough, but a demonstration of the effectivity of using the existing method and even the existing equipment to significantly increase the volume of samples tested per day,” Roy Kishony, one of the researchers behind the Israeli study, said in a statement.

“This approach should reduce the chance of infection and flatten the infection curve,” he concluded.

Related
Potato chips or heroin? The debate on social media and mental health
Experts disagree on whether social media causes mental health issues in adolescents despite looking at the same data. Here’s why.
Scientists have invented a method to break down “forever chemicals” in our drinking water
Researchers have discovered a way to eliminate “forever chemicals,” or PFAS, which usually take hundreds or thousands of years to break down.
When an antibiotic fails: MIT scientists are using AI to target “sleeper” bacteria
Most antibiotics target metabolically active bacteria, but AI can help efficiently screen compounds that are lethal to dormant microbes.
The threat of avian flu — and what we can do to stop it
Avian flu is infecting cows on US dairy farms, and now a person has caught it — but new research could help us avoid a bird flu pandemic.
What’s next for COVID-19 drugs?
Paxlovid may have underperformed in a new trial, but other promising COVID-19 drugs are being authorized or in the works.
Up Next
Coronavirus Masks
Subscribe to Freethink for more great stories